We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRED
1601
DELISTED
Fred's Inc
FRED
| $1.49M | ﹤0.01% |
87,314
-50,231
| -37% | -$899K |
|
1602
iShares Russell Mid-Cap ETF
IWR
$56.7B
| $1.49M | ﹤0.01% |
34,400
+25,660
| +294% | +$1.09M |
|
1603
PBF Energy
PBF
$7.3B
| $1.49M | ﹤0.01% |
43,845
+930
| +2% | +$27K |
|
1604
GSK
GSK
$104B
| $1.48M | ﹤0.01% |
25,720
-1,840
| -7% | -$105K |
|
|
EGOV
1605
DELISTED
NIC Inc
EGOV
| $1.48M | ﹤0.01% |
83,979
-92,419
| -52% | -$1.57M |
|
1606
Agios Pharmaceuticals
AGIO
$1.92B
| $1.48M | ﹤0.01% |
15,726
+3,005
| +24% | +$337K |
|
|
BPFH
1607
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.48M | ﹤0.01% |
121,933
-100
| -0.1% | -$1.23K |
|
|
DOC
1608
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.48M | ﹤0.01% |
84,110
+25,880
| +44% | +$437K |
|
1609
First Commonwealth Financial
FCF
$2.18B
| $1.48M | ﹤0.01% |
164,269
+6,850
| +4% | +$58.9K |
|
|
BGG
1610
DELISTED
Briggs & Stratton Corp.
BGG
| $1.48M | ﹤0.01% |
71,956
+500
| +0.7% | +$9.84K |
|
|
NTUS
1611
DELISTED
Natus Medical Inc
NTUS
| $1.48M | ﹤0.01% |
37,417
+3,790
| +11% | +$140K |
|
|
CCMP
1612
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.48M | ﹤0.01% |
29,567
+2,475
| +9% | +$122K |
|
1613
Employers Holdings
EIG
$910M
| $1.48M | ﹤0.01% |
54,650
+4,025
| +8% | +$94.3K |
|
1614
Standex International
SXI
$4.06B
| $1.47M | ﹤0.01% |
17,931
+1,625
| +10% | +$120K |
|
1615
Halozyme
HALO
$9.84B
| $1.47M | ﹤0.01% |
103,058
+16,740
| +19% | +$241K |
|
|
CSOD
1616
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $1.47M | ﹤0.01% |
50,947
+6,965
| +16% | +$227K |
|
|
HF
1617
DELISTED
HFF Inc.
HF
| $1.47M | ﹤0.01% |
39,186
+4,950
| +14% | +$178K |
|
1618
Piper Sandler
PIPR
$5.09B
| $1.47M | ﹤0.01% |
111,764
+6,900
| +7% | +$93.7K |
|
1619
Antero Resources
AR
$10.7B
| $1.46M | ﹤0.01% |
41,459
+1,270
| +3% | +$47.7K |
|
1620
Bright Horizons
BFAM
$3.89B
| $1.46M | ﹤0.01% |
28,559
+4,810
| +20% | +$239K |
|
|
PIR
1621
DELISTED
Pier 1 Imports, Inc.
PIR
| $1.46M | ﹤0.01% |
5,225
+600
| +13% | +$174K |
|
1622
Metallus
MTUS
$890M
| $1.46M | ﹤0.01% |
55,048
+2,230
| +4% | +$65.6K |
|
|
TYPE
1623
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.46M | ﹤0.01% |
44,589
+4,000
| +10% | +$124K |
|
1624
Spectrum Brands
SPB
$2.04B
| $1.45M | ﹤0.01% |
16,179
+700
| +5% | +$65.4K |
|
1625
Stewart Information Services
STC
$2.09B
| $1.45M | ﹤0.01% |
35,615
+200
| +0.6% | +$7.48K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.